Targeting tumor immunity with transferrin receptor-directed photodynamic therapy

This new article publication from Acta Pharmaceutica Sinica B, discusses a transferrin receptor-targeted immunostimulant for photodynamic immunotherapy against metastatic tumors through β-catenin/CREB interruption.

Brain study reveals cause of apathy in schizophrenia

Schizophrenia, which affects up to 1% of the population, is a neuropsychiatric disorder characterized by multiple symptoms.

July 2, 2024

Congress Halts Hearing On Psychedelics & Veterans As House Speaker Drama Continues

A hearing of the House VA’s subcommittee on Health around the use of psychedelic-assisted therapies for mental health disorders originally scheduled for Thursday was postponed following the ongoing failed

October 20, 2023

LVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variants

Announcing a new article publication for Zoonoses journal. The global coronavirus disease 2019 (COVID-19) pandemic was caused by SARS-CoV-2.

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.